New cancer clinical trial: First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer, Coupled to Extensive Translational Studies

Published on: January 15, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share